Option Care Health Q3 revenue up 17% but EPS flat; cuts FY2024 guidance on IV bag supply disruption

Option Care Health, Inc.

2024-Q3 EPS reported $0.87 revenue$3,651,784,000

Net revenue of $1,278.5M (+17.0% YoY); gross margin fell to 20.1% from 23.3%.
Diluted EPS $0.31 (GAAP) and adjusted diluted EPS $0.41, both roughly flat YoY.
Adjusted EBITDA of $115.6M (+5.3% YoY); operating cash flow $160.4M vs $61.0M.
Hurricane Helene disrupted IV solution bag supply; expects negative Q4 impact.
FY2024 guidance trimmed: revenue $4.9B-$4.95B, Adj. EBITDA $438M-$443M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.